相似文献
1
Immune Modulation in Critically Ill Septic Patients.
Medicina (Kaunas). 2021 May 31;57(6):552. doi: 10.3390/medicina57060552.
2
Hemadsorption.
Curr Opin Anaesthesiol. 2021 Apr 1;34(2):113-118. doi: 10.1097/ACO.0000000000000953.
3
Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission.
J Nephrol. 2023 Sep;36(7):1731-1742. doi: 10.1007/s40620-023-01637-5. Epub 2023 Jul 13.
4
Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children.
Medicina (Kaunas). 2019 Jul 7;55(7):350. doi: 10.3390/medicina55070350.
5
Immune-modulating interventions in critically ill septic patients: pharmacological options.
Expert Rev Clin Pharmacol. 2011 Jul;4(4):491-501. doi: 10.1586/ecp.11.25.
6
Sequential Extracorporeal Therapy in Sepsis.
Contrib Nephrol. 2023;200:149-159. doi: 10.1159/000527573. Epub 2023 Jun 8.
7
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.
Crit Care. 2018 Oct 25;22(1):262. doi: 10.1186/s13054-018-2181-z.
8
Blood purification in sepsis: a new paradigm.
Contrib Nephrol. 2010;165:322-328. doi: 10.1159/000313773. Epub 2010 Apr 20.
9
Extracorporeal renal replacement therapies in the treatment of sepsis: where are we?
Semin Nephrol. 2015 Jan;35(1):55-63. doi: 10.1016/j.semnephrol.2015.01.006.
10
Extracorporeal therapies in the treatment of sepsis: experience and promise.
Semin Pediatr Infect Dis. 2006 Apr;17(2):72-9. doi: 10.1053/j.spid.2006.04.005.
引用本文的文献
1
The effects of saffron supplementation on inflammation and hematological parameters in patients with sepsis: a randomized controlled trial.
Nutr J. 2025 May 9;24(1):72. doi: 10.1186/s12937-025-01148-y.
2
Vitamin D supplementation during intensive care unit stay is associated with improved outcomes in critically Ill patients with sepsis: a cohort study.
Front Cell Infect Microbiol. 2025 Jan 20;14:1485554. doi: 10.3389/fcimb.2024.1485554. eCollection 2024.
3
Effect of calcitriol supplementation on infectious biomarkers in patients with positive systemic inflammatory response: A Randomized Controlled Trial.
Ann Med Surg (Lond). 2024 Jan 3;86(2):875-880. doi: 10.1097/MS9.0000000000001643. eCollection 2024 Feb.
4
Update on vitamin D role in severe infections and sepsis.
J Anesth Analg Crit Care. 2024 Jan 23;4(1):4. doi: 10.1186/s44158-024-00139-5.
5
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review.
Microorganisms. 2023 Feb 13;11(2):473. doi: 10.3390/microorganisms11020473.
6
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup.
Nat Rev Nephrol. 2023 Jun;19(6):401-417. doi: 10.1038/s41581-023-00683-3. Epub 2023 Feb 23.
7
Vitamin D Status and Potential Therapeutic Options in Critically Ill Patients: A Narrative Review of the Clinical Evidence.
Diagnostics (Basel). 2022 Nov 7;12(11):2719. doi: 10.3390/diagnostics12112719.
8
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.
Front Immunol. 2022 Jun 27;13:870632. doi: 10.3389/fimmu.2022.870632. eCollection 2022.
9
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.
PLoS One. 2022 Apr 28;17(4):e0267038. doi: 10.1371/journal.pone.0267038. eCollection 2022.
10
Sepsis: New Challenges and Future Perspectives for an Evolving Disease-Precision Medicine Is the Way!
Medicina (Kaunas). 2021 Oct 15;57(10):1109. doi: 10.3390/medicina57101109.
本文引用的文献
1
COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.
J Crit Care. 2021 Aug;64:173-175. doi: 10.1016/j.jcrc.2021.04.008. Epub 2021 Apr 18.
2
Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway.
Front Immunol. 2021 Feb 17;11:624279. doi: 10.3389/fimmu.2020.624279. eCollection 2020.
3
Hemadsorption.
Curr Opin Anaesthesiol. 2021 Apr 1;34(2):113-118. doi: 10.1097/ACO.0000000000000953.
4
Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry.
Artif Organs. 2021 Jun;45(6):E187-E194. doi: 10.1111/aor.13900. Epub 2021 Feb 17.
5
Extracorporeal immune modulation in COVID-19 induced immune dysfunction and secondary infections: the role of oXiris® membrane.
Minerva Anestesiol. 2021 Mar;87(3):384-385. doi: 10.23736/S0375-9393.20.15124-1. Epub 2020 Dec 17.
6
Therapeutic Potential of Heme Oxygenase-1 and Carbon Monoxide in Acute Organ Injury, Critical Illness, and Inflammatory Disorders.
Antioxidants (Basel). 2020 Nov 19;9(11):1153. doi: 10.3390/antiox9111153.
7
Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study.
Crit Care. 2020 Oct 12;24(1):605. doi: 10.1186/s13054-020-03322-6.
8
Temporal Differential Expression of Physiomarkers Predicts Sepsis in Critically Ill Adults.
Shock. 2021 Jul 1;56(1):58-64. doi: 10.1097/SHK.0000000000001670.
9
The interaction between the complement system and hemostatic factors.
Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605.
10
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
Zotero 插件